A 61-year-old woman with T2D and CKD (eGFR 52; UACR 200 mg/g) is on metformin. Which additional agent slows CKD progression and provides CV benefit?...

Question

A 61-year-old woman with T2D and CKD (eGFR 52; UACR 200 mg/g) is on metformin. Which additional agent slows CKD progression and provides CV benefit?

Accepted Answer

SGLT2 inhibitor

Answer

DPP-4 inhibitor

Answer

SU sulfonylurea

Answer

Thiazolidinedione

Answer

Basal insulin

"ada standards of care (2025): pharmacologic approaches to glycemic treatment" MCQ (SBA): Type 2 Diabetes Mell